Background Stromal-Derived Inducing Activity (SDIA) is one of the most efficient methods of generating dopaminergic (DA) neurons from embryonic stem cells (ESC). DA neuron induction can be achieved by co-culturing ESC with the mouse stromal cell lines PA6 or MS5. The molecular nature of this effect, which has been termed “SDIA” is so far unknown. Recently, we found that factors secreted by PA6 cells provided lineage-specific instructions to induce DA differentiation of human ESC (hESC). Methodology/Principal Findings In the present study, we compared PA6 cells to various cell lines lacking the SDIA effect, and employed genome expression analysis to identify differentially-expressed signaling molecules. Among the factors highly expressed by PA6 cells, and known to be associated with CNS development, were stromal cell-derived factor 1 (SDF-1/CXCL12), pleiotrophin (PTN), insulin-like growth factor 2 (IGF2), and ephrin B1 (EFNB1). When these four factors, the combination of which was termed SPIE, were applied to hESC, they induced differentiation to TH-positive neurons in vitro. RT-PCR and western blot analysis confirmed the expression of midbrain specific markers, including engrailed 1, Nurr1, Pitx3, and dopamine transporter (DAT) in cultures influenced by these four molecules. Electrophysiological recordings showed that treatment of hESC with SPIE induced differentiation of neurons that were capable of generating action potentials and forming functional synaptic connections. Conclusions/Significance The combination of SDF-1, PTN, IGF2, and EFNB1 mimics the DA phenotype-inducing property of SDIA and was sufficient to promote differentiation of hESC to functional midbrain DA neurons. These findings provide a method for differentiating hESC to form DA neurons, without a requirement for the use of animal-derived cell lines or products.
References
[1]
Schulz TC, Noggle SA, Palmarini GM, Weiler DA, Lyons IG, et al. (2004) Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells 22: 1218–1238.
[2]
Yan Y, Yang D, Zarnowska ED, Du Z, Werbel B, et al. (2005) Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 23: 781–790.
[3]
Park CH, Minn YK, Lee JY, Choi DH, Chang MY, et al. (2005) In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J Neurochem 92: 1265–1276.
[4]
Zeng X, Cai J, Chen J, Luo Y, You ZB, et al. (2004) Dopaminergic differentiation of human embryonic stem cells. Stem Cells 22: 925–940.
[5]
Cho MS, Lee YE, Kim JY, Chung S, Cho YH, et al. (2008) Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A 105: 3392–3397.
[6]
Sonntag KC, Pruszak J, Yoshizaki T, van Arensbergen J, Sanchez-Pernaute R, et al. (2007) Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 25: 411–418.
[7]
Schulz TC, Palmarini GM, Noggle SA, Weiler DA, Mitalipova MM, et al. (2003) Directed neuronal differentiation of human embryonic stem cells. BMC Neurosci 4: 27.
[8]
Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, et al. (2000) Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28: 31–40.
[9]
Barberi T, Klivenyi P, Calingasan NY, Lee H, Kawamata H, et al. (2003) Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in Parkinsonian mice. Nat Biotechnol 21: 1200–1207.
[10]
Perrier AL, Tabar V, Barberi T, Rubio ME, Bruses J, et al. (2004) Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A 101: 12543–12548.
[11]
Morizane A, Takahashi J, Takagi Y, Sasai Y, Hashimoto N (2002) Optimal conditions for in vivo induction of dopaminergic neurons from embryonic stem cells through stromal cell-derived inducing activity. J Neurosci Res 69: 934–939.
[12]
Shimozaki K, Nakashima K, Niwa H, Taga T (2003) Involvement of Oct3/4 in the enhancement of neuronal differentiation of ES cells in neurogenesis-inducing cultures. Development 130: 2505–2512.
[13]
Takagi Y, Takahashi J, Saiki H, Morizane A, Hayashi T, et al. (2005) Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 115: 102–109.
[14]
Yue F, Cui L, Johkura K, Ogiwara N, Sasaki K (2006) Induction of midbrain dopaminergic neurons from primate embryonic stem cells by coculture with sertoli cells. Stem Cells 24: 1695–1706.
[15]
Hayashi H, Morizane A, Koyanagi M, Ono Y, Sasai Y, et al. (2008) Meningeal cells induce dopaminergic neurons from embryonic stem cells. Eur J Neurosci 27: 261–268.
[16]
Buytaert-Hoefen KA, Alvarez E, Freed CR (2004) Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF. Stem Cells 22: 669–674.
[17]
Roy NS, Cleren C, Singh SK, Yang L, Beal MF, et al. (2006) Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12: 1259–1268.
[18]
Chiba S, Lee YM, Zhou W, Freed CR (2008) Noggin enhances dopamine neuron production from human embryonic stem cells and improves behavioral outcome after transplantation into Parkinsonian rats. Stem Cells 26(11): 2810–2820.
[19]
Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD (2000) Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 18: 675–679.
[20]
Lau T, Adam S, Schloss P (2006) Rapid and efficient differentiation of dopaminergic neurons from mouse embryonic stem cells. Neuroreport 17: 975–979.
[21]
Schwartz CM, Spivak CE, Baker SC, McDaniel TK, Loring JF, et al. (2005) NTera2: A model system to study dopaminergic differentiation of human embryonic stem cells. Stem Cells Dev 14: 517–534.
[22]
Yamazoe H, Murakami Y, Mizuseki K, Sasai Y, Iwata H (2005) Collection of neural inducing factors from PA6 cells using heparin solution and their immobilization on plastic culture dishes for the induction of neurons from embryonic stem cells. Biomaterials 26: 5746–5754.
[23]
Vazin T, Chen J, Lee CT, Amable R, Freed WJ (2008) Assessment of stromal-derived inducing activity in the generation of dopaminergic neurons from human embryonic stem cells. Stem Cells 26(6): 1517–1525.
[24]
Vazin T, Chen J, Spivak CE, Amable R, Gabitzsch E, et al. (2008) Dopaminergic neurons derived from BG01V2, a variant of human embryonic stem cell line BG01. Restor Neurol Neurosci 26(6): 447–458.
[25]
Cheadle C, Vawter MP, Freed WJ, Becker KG (2003) Analysis of microarray data using Z score transformation. J Mol Diagn 5(2): 73–81.
[26]
Al-Shahrour F, Díaz-Uriarte R, Dopazo J (2004) A web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics 20(4): 578–580.
[27]
Murase K, Ryu PD, Randic M (1989) Excitatory and inhibitory amino acids and peptide-induced responses in acutely isolated rat spinal dorsal horn neurons. Neurosci Lett 103(1): 56–63.
[28]
Berger B, Di Porzio U, Daguet MC, Gay M, Vigny A, et al. (1982) Long-term development of mesencephalic dopaminergic neurons of mouse embryos in dissociated primary cultures: morphological and histochemical characteristics. Neuroscience 7(1): 193–205.
[29]
Hayashi H, Morizane A, Koyanagi M, Ono Y, Sasai Y, et al. (2008) Meningeal cells induce dopaminergic neurons from embryonic stem cells. Eur J Neurosci 27: 261–268.
[30]
Freed WJ, Chen J, B？ckman CM, Schwartz CM, Vazin T, et al. (2008) Gene expression profile of neuronal progenitor cells derived from hESCs: Activation of chromosome 11p15.5 and comparison to human dopaminergic neurons. PLoS ONE 9(1): e1422.
[31]
Bhattacharya B, Cai J, Luo Y, Miura T, Mejido J, et al. (2005) Comparison of the gene expression profile of undifferentiated human embryonic stem cell lines and differentiating embryoid bodies. BMC Dev Biol 5: 22.
[32]
Brimble SN, Zeng X, Weiler DA, Luo Y, Liu Y, et al. (2004) Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev 13(6): 585–597.
[33]
Smidt MP, Asbreuk CH, Cox JJ, Chen H, Johnson RL, et al. (2000) A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat Neurosci 3(4): 337–341.
[34]
Nunes I, Tovmasian LT, Silva RM, Burke RE, Goff SP (2003) Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc Natl Acad Sci U S A 100(7): 4245–50.
[35]
Simon HH, Saueressig H, Wurst W, Goulding MD, O'Leary DD (2001) Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J Neurosci 21(9): 3126–3134.
[36]
Cacalano G, Fari？as I, Wang LC, Hagler K, Forgie A, et al. (1998) GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 21(1): 53–62.
[37]
Trupp M, Arenas E, Fainzilber M, Nilsson AS, Sieber BA (1996) Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381(6585): 785–789.
[38]
Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260(5111): 1130–1132.
[39]
Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, et al. (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350(6315): 230–232.
[40]
Squinto SP, Stitt TN, Aldrich TH, Davis S, Bianco SM, et al. (1991) trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 65(5): 885–893.
[41]
Apionishev S, Katanayeva NM, Marks SA, Kalderon D, Tomlinson A (2005) Drosophila Smoothened phosphorylation sites essential for Hedgehog signal transduction. Nat Cell Biol 7(1): 86–92.
[42]
Perrimon N, Bernfield M (2000) Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404(6779): 725–728.
[43]
Lin X (2004) Functions of heparan sulfate proteoglycans in cell signaling during development. Development 131(24): 6009–6021.
[44]
Kinnunen T, Raulo E, Nolo R, Maccarana M, Lindahl U, et al. (1996) Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface. J Biol Chem 271(4): 2243–2248.
[45]
Marchionini DM, Lehrmann E, Chu Y, He B, Sortwell CE, et al. (2007) Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease. Brain Res 1147: 77–88.
[46]
Jung CG, Hida H, Nakahira K, Ikenaka K, Kim HJ, et al. (2004) Pleiotrophin mRNA is highly expressed in neural stem (progenitor) cells of mouse ventral mesencephalon and the product promotes production of dopaminergic neurons from embryonic stem cell-derived nestin-positive cells. FASEB J 18(11): 1237–1239.
[47]
Mansuy IM, van der Putten H, Schmid P, Meins M, Botteri FM, et al. (1993) Variable and multiple expression of Protease Nexin-1 during mouse organogenesis and nervous system development. Development 119(4): 1119–1134.
[48]
Ohuchi H, Nakagawa T, Yamamoto A, Araga A, Ohata T, et al. (1997) The mesenchymal factor, FGF10, initiates and maintains the outgrowth of the chick limb bud through interaction with FGF8, an apical ectodermal factor. Development 124(11): 2235–2244.
[49]
Kawakami Y, Capdevila J, Büscher D, Itoh T, Rodríguez Esteban C, et al. (2001) WNT signals control FGF-dependent limb initiation and AER induction in the chick embryo. Cell 104(6): 891–900.
[50]
Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA (1996) A highly efficacious lymphocyte chemoattractant: Stromal cell-derived factor 1 (SDF-1). J Exp Med 184(3): 1101–1109.
[51]
Tham TN, Lazarini F, Franceschini IA, Lachapelle F, Amara A, et al. (2001) Developmental pattern of expression of the alpha chemokine stromal cell-derived factor 1 in the rat central nervous system. Eur J Neurosci 13(5): 845–856.
[52]
Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, et al. (1998) Impaired B-lymphopoiesis: Myelopoiesis and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A 95: 9448–9453.
[53]
Luo Y, Cai J, Xue H, Mattson MP, Rao MS (2006) SDF1alpha/CXCR4 signaling stimulates beta-catenin transcriptional activity in rat neural progenitors. Neurosci Lett 398(3): 291–295.
[54]
Klein RS, Rubin JB, Gibson HD, DeHaan EN, Alvarez-Hernandez X, et al. (2001) SDF-1 alpha induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells. Development 128(11): 1971–1981.
[55]
Luo Y, Cai J, Liu Y, Xue H, Chrest FJ, et al. (2002) Microarray analysis of selected genes in neural stem and progenitor cells. J Neurochem 83(6): 1481–1497.
[56]
Edman LC, Mira H, Erices A, Malmersj？ S, Andersson E, et al. (2008) Alpha-chemokines regulate proliferation, neurogenesis, and dopaminergic differentiation of ventral midbrain precursors and neurospheres. Stem Cells 26(7): 1891–1900.
[57]
Rotwein P, Burgess SK, Milbrandt JD, Krause JE (1988) Differential expression of insulin-like growth factor genes in rat central nervous system. Proc Natl Acad Sci U S A 85(1): 265–269.
[58]
Bondy C, Werner H, Roberts CT Jr, LeRoith D (1992) Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain comparison with insulin-like growth factors I and II. Neuroscience 46(4): 909–923.
[59]
Feldman EL, Sullivan KA, Kim B, Russell JW (1997) Insulin-like growth factors regulate neuronal differentiation and survival. Neurobiol Dis 4(3–4): 201–214.
[60]
Russo VC, Gluckman PD, Feldman EL, Werther GA (2005) The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev. 26(7): 916–43.
[61]
Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins biological actions. Endocr Rev 16(1): 3–34.
[62]
Brar AK, Chernausek SD (1993) Localization of insulin-like growth factor binding protein-4 expression in the developing and adult rat brain: Analysis by in situ hybridization. J Neurosci Res 35(1): 103–114.
[63]
Yu S, Zhang JZ, Xu Q (2006) Genes associated with neuronal differentiation of precursors from humain brain. Neuroscience 141(2): 817–825.
[64]
Pintar JE, Cerro J, Streck R, Wood T, Rogler L, et al. (1994) Expression and function of IGFBPs during rodent development. In: Baxter RC, Gluckman PD, Rosenfeld RG, editors. The Insulin-Like Growth Factors and Their Regulatory Proteins. Amsterdam: Elsevier Science. pp. 253–561.
[65]
Palmer A, Klein R (2003) Multiple roles of ephrins in morphogenesis: Neuronal networking and brain function. Genes Dev 17(12): 1429–1450.
[66]
Davy A, Aubin J, Soriano P (2004) Ephrin-B1 forward and reverse signaling are required during mouse development. Genes Dev 18(5): 572–583.
[67]
Santiago A, Erickson CA (2002) Ephrin-B ligands play a dual role in the control of neural crest cell migration. Development 129(15): 3621–3632.
[68]
Yue Y, Widmer DA, Halladay AK, Cerretti DP, Wagner GC, et al. (1999) Specification of distinct dopaminergic neural pathways: Roles of the Eph family receptor EphB1 and ligand ephrin-B2. J Neurosci 19(6): 2090–2101.
[69]
Farkas LM, Dünker N, Roussa E, Unsicker K, Krieglstein K (2003) Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. J Neurosci 23(12): 5178–5186.
[70]
Castelo-Branco G, Arenas E (2006) Function of Wnts in dopaminergic neuron development. Neurodegener Dis 3(1–2): 5–11.
[71]
Kele-Olovsson , Julianna MV (2007) Regulation of midbrain dopaminergic neuron development by Wnts, Sfrps and bHLH proteins.
